{"artifact":{"id":"open_question-027781c9-5e2f-4029-9050-de4ff7209aff","artifact_type":"open_question","entity_ids":"[\"therapeutics\"]","title":"Combination approaches**: What are the best combinations with other agents?","quality_score":0.5,"created_by":"backfill_open_questions","provenance_chain":"[]","content_hash":"7bf8c791869a533575f2e3eb14d83b604c606075b87d04647739c1ccdb581ce8","metadata":{"status":"open","_origin":{"url":null,"type":"internal","tracked_at":"2026-04-26T03:28:44.781235"},"field_tag":"therapeutics","source_id":"therapeutics-glp-1-receptor-agonists-neurodegeneration","sub_field":"glp-1-receptor-agonists-neurodegeneration","source_kind":"wiki","question_hash":"bf2502c17b9b61be2cec3c49edd18d89bbd0e67793af1397d83d5feac7e523e7","question_text":"Combination approaches**: What are the best combinations with other agents?","importance_elo":1500,"_schema_version":1,"evidence_summary":"Extracted from wiki page therapeutics-glp-1-receptor-agonists-neurodegeneration","tractability_score":0.5,"potential_impact_score":0.5},"created_at":"2026-04-25T20:28:44.781377-07:00","updated_at":"2026-04-25T20:28:44.781377-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-25T20:28:44.781377-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"7ed85505-4242-4fea-9390-91662547a78a","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"backfill_open_questions"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-therapeutics-glp-1-receptor-agonists-neurodegeneration","link_type":"derives_from","strength":0.9,"evidence":"{\"method\": \"open_question_wiki_crosslink\", \"cycle\": \"artifact-enrichment-2026-04-27\"}"}],"incoming_links":[],"current_artifact_id":"open_question-027781c9-5e2f-4029-9050-de4ff7209aff","is_canonical":true,"supersede_chain":["open_question-027781c9-5e2f-4029-9050-de4ff7209aff"]}